PharmaSGP Holding SE
April 18, 2024
PharmaSGP Holding SE
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
View Article
April 16, 2024
PharmaSGP Holding SE
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
View Article
November 14, 2023
PharmaSGP Holding SE
PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
View Article
September 14, 2023
PharmaSGP Holding SE
PharmaSGP achieves top performance in the first half of 2023
View Article
June 29, 2023
PharmaSGP Holding SE
PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
View Article
May 10, 2023
PharmaSGP Holding SE
PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40%
View Article
April 19, 2023
PharmaSGP Holding SE
PharmaSGP plans dividend distribution of 49.2% after record year in 2022
View Article
March 15, 2023
PharmaSGP Holding SE
PharmaSGP confirms record revenue and record profitability for 2022 and publishes forecast for 2023
View Article
March 14, 2023
PharmaSGP Holding SE
PharmaSGP Holding SE releases forecast for full year 2023
View Article
January 03, 2023
PharmaSGP Holding SE
PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro
View Article
November 16, 2022
PharmaSGP Holding SE
PharmaSGP posts record revenues (+39%) and record earnings (+54%) in 9M 2022 – raises full-year forecast
View Article
November 10, 2022
PharmaSGP Holding SE
PharmaSGP Holding SE raises forecast for FY 2022
View Article